WebJun 27, 2024 · In TNBC patients received anti- PD-L1 plus nab-paclitaxel therapy, the pooled ORR was 49.7% (95% CI: 33.9–65.5%) in overall population, and 55.8% (95% CI: 42.9–68.6%) in PD-L1 + population. The ORR of anti- PD-L1 monotherapy in TNBC was 9.6% (95% CI: 4.2–15.0%) in overall population and 12.1% (95% CI: 5.4–18.8%) in PD … WebApr 10, 2024 · We also analyzed the response to PD-1 blockade plus nab-paclitaxel-based regimen in patients who had not received prior immunotherapy. A total of 14 patients received chemotherapy alone in the first-line, and five received a combination of anti-PD-1 antibody plus nab-paclitaxel, with an ORR of 60.0%. The other nine patients received …
The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: …
WebJun 4, 2024 · The anti–PD-L1 antibody atezolizumab (Tecentriq, F. Hoffmann–La Roche/Genentech) 6,7 has been shown to provide an overall survival benefit in patients with previously treated metastatic NSCLC... WebJul 17, 2024 · 1/2期 胰腺癌 联合Gemcitabine and Albumin Paclitaxel NCT04624217. 1期转移性或局部晚期实体瘤 NCT03710265. ... Cheng B et al,Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer.Cancer Commun (Lond). 2024 Jan;42(1):17-36. ... howell general baptist church sermon
Atezolizumab Combo Approved for PD-L1–positive TNBC
WebApr 10, 2024 · Voorwerk et al. report the clinical and translational results from a phase II trial evaluating the combination of carboplatin with anti-PD-L1 in patients with invasive lobular breast cancer, who ... WebOct 21, 2024 · Paclitaxel is an anti-cancer medication used for the treatment of breast cancer, pancreatic cancer, and non-small cell lung cancer. It is given as an intravenous … WebPembrolizumab is the first immunotherapy to be approved by US FDA for PD-L1 expressing gastric and gastroesopahgeal junction (GEJ) cancers after they have progressed on at least two prior lines of treatment. ... assessing single agent pembrolizumab vs paclitaxel in PD-L1-positive advanced, metastatic gastric and GEJ adenocarcinomas (including ... howell georgia